BiochemProbe — Life Science Research Reagents

BMS 605541 free base · Synonyms: BMS-605541 · BMS605541

BMS-605541 is a selective and orally active inhibitor of VEGFR-2 kinase.

For research use only. Not for human or veterinary use.

Target VEGFR PDGFR
Research area Cancer
Purity >98% Stock Inquire

BMS 605541 structure

CAS No.: 639858-32-5

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
250 mg USD 320.00 BP-02208-250mg In stock Get quote
500 mg USD 510.00 BP-02208-100mg In stock Get quote
1 g USD 815.00 BP-02208-1g In stock Get quote
2 g USD 1,310.00 BP-02208-2g In stock Get quote
3 g USD 1,560.00 BP-02208-3g In stock Get quote
5 g USD 2,090.00 BP-02208-5g In stock Get quote
10 g USD 3,350.00 BP-02208-10g In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

BMS-605541 is a selective and orally active inhibitor of VEGFR-2 kinase with an IC50 value of 23 nM and Ki value of 49 nM. BMS-605541 inhibits the activity of Flk-1, VEGFR-1 and PDGFR-β with IC50 values of 40 nM, 400 nM and 200 nM, respectively. BMS-605541 can be used for cancer research[1].

Biological activity

In Vitro BMS-605541 (Compound 14) inhibits the growth of HUVECs through VEGF with an IC50 value of 25 nM. In Vivo BMS-605541 (12.5-180 mg/kg; once a day or twice a day for 14 days) has anti-tumor activity in thymic mice subcutaneously implanted with L2987 and HCT-116 xenografts.

Identifiers

SMILES
FC1=C(C=C(C(F)=C1)C(NC2CC2)=O)NCC3=CN=C(S3)NC4=NC=CC=C4
InChIKey
CUPLTRAPYIXFAX-UHFFFAOYSA-N

Specifications

MW (average)
401.4330
Formula
C19H17F2N5OS
CAS No.
639858-32-5
Physical state
Solid
Color
White to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 3 years; 4℃ 2 years; In solvent -20℃ 1 month;

Solubility

soluble in DMSO

References

[1]. Borzilleri RM, et al. Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2. J Med Chem. 2006 Jun 29;49(13):3766-9.

Same target

Search VEGFR

Same research area

Search Cancer